is O O O O
part O O O O
of O O O O
SSRN´s O O O O
First O O O O
Look, O O O O
a O O O O
place O O O O
where O O O O
journals O O O O
identify O O O O
content O O O O
of O O O O
interest O O O O
prior O O O O
to O O O O
publication. O O O O
Authors O O O O
have O O O O
opted O O O O
in O O O O
at O O O O
submission O O O O
to O O O O
The O O O O
Lancet O O O O
family O O O O
of O O O O
journals O O O O
to O O O O
post O O O O
their O O O O
preprints O O O O
on O O O O
Preprints O O O O
with O O O O
The O O O O
Lancet. O O O O
The O O O O
usual O O O O
SSRN O O O O
checks O O O O
and O O O O
a O O O O
Lancet-specific O O O O
check O O O O
for O O O O
appropriateness O O O O
and O O O O
transparency O O O O
have O O O O
been O O O O
applied. O O O O
Preprints O O O O
available O O O O
here O O O O
are O O O O
not O O O O
Lancet O O O O
publications O O O O
or O O O O
necessarily O O O O
under O O O O
review O O O O
with O O O O
a O O O O
Lancet O O O O
journal. O O O O
These O O O O
preprints O O O O
are O O O O
early O O O O
stage O O O O
research O O O O
papers O O O O
that O O O O
have O O O O
not O O O O
been O O O O
peer-reviewed. O O O O
The O O O O
findings O O O O
should O O O O
not O O O O
be O O O O
used O O O O
for O O O O
clinical O O O O
or O O O O
public O O O O
health O O O O
decision O O O O
making O O O O
and O O O O
should O O O O
not O O O O
be O O O O
presented O O O O
to O O O O
a O O O O
lay O O O O
audience O O O O
without O O O O
highlighting O O O O
that O O O O
they O O O O
are O O O O
preliminary O O O O
and O O O O
have O O O O
not O O O O
been O O O O
peer-reviewed. O O O O
For O O O O
more O O O O
information O O O O
on O O O O
this O O O O
collaboration, O O O O
see O O O O
the O O O O
comments O O O O
published O O O O
in O O O O
The O O O O
Lancet O O O O
about O O O O
the O O O O
[trial](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31125-5/fulltext) O O O O
period, O O O O
and O O O O
our O O O O
decision O O O O
to O O O O
make O O O O
this O O O O
a O O O O
[permanent](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31950-4/fulltext) O O O O
offering, O O O O
or O O O O
visit O O O O
The O O O O
Lancet´s O O O O
[FAQ](https://www.thelancet.com/preprints) O O O O
page, O O O O
and O O O O
for O O O O
any O O O O
feedback O O O O
please O O O O
contact O O O O
[preprints@lancet.com](mailto:preprints@lancet.com). O O O O
Cancer Reason 3 O O
Associates Reason 3 O O
with Reason 3 O O
Risk Reason 3 O O
and Reason 3 O O
Severe Reason 3 O O
Events Reason 3 O O
of Reason 3 O O
COVID-19: Reason 3 O O
A Reason 3 O O
Systematic Reason 3 O O
Review Reason 3 O O
and Reason 3 O O
Meta-Analysis Reason 3 O O
26 Reason 3 O O
Pages Reason 3 O O
Posted: Reason 3 O O
10 Reason 3 O O
Jul Reason 3 O O
2020 Reason 3 O O
[More...](javascript:void(0);) Reason 3 O O
Abstract Reason 3 O O
Background: Reason 3 O O
There Reason 3 O O
have Reason 3 O O
been Reason 3 O O
inconsistent Reason 3 O O
reports Reason 3 O O
with Reason 3 O O
a Reason 3 O O
small Reason 3 O O
size Reason 3 O O
of Reason 3 O O
study Reason 3 O O
that Reason 3 O O
patients Reason 3 O O
of Reason 3 O O
cancer Reason 3 O O
are Reason 3 O O
likely Reason 3 O O
associated Reason 3 O O
with Reason 3 O O
the Reason 3 O O
development Reason 3 O O
of Reason 3 O O
COVID-19 Reason 3 O O
after Reason 3 O O
infection Reason 3 O O
with Reason 3 O O
the Reason 3 O O
severe Reason 3 O O
acute Reason 3 O O
respiratory Reason 3 O O
syndrome Reason 3 O O
coronavirus-2. Reason 3 O O
A Reason 3 O O
robust Reason 3 O O
estimate Reason 3 O O
is Reason 3 O O
needed Reason 3 O O
urgently Reason 3 O O
to Reason 3 O O
convey Reason 3 O O
appropriate Reason 3 O O
information Reason 3 O O
to Reason 3 O O
the Reason 3 O O
society Reason 3 O O
and Reason 3 O O
the Reason 3 O O
public, Reason 3 O O
in Reason 3 O O
the Reason 3 O O
time Reason 3 O O
of Reason 3 O O
ongoing Reason 3 O O
pandemic Reason 3 O O
of Reason 3 O O
COVID-19. Reason 3 O O
Methods: Reason 3 O O
We Reason 3 O O
performed Reason 3 O O
a Reason 3 O O
systematic Reason 3 O O
review Reason 3 O O
and Reason 3 O O
meta-analysis Reason 3 O O
through Reason 3 O O
a Reason 3 O O
systematic Reason 3 O O
literature Reason 3 O O
search Reason 3 O O
on Reason 3 O O
PubMed, Reason 3 O O
Elsevier Reason 3 O O
and Reason 3 O O
Web Reason 3 O O
of Reason 3 O O
Science, Reason 3 O O
additionally Reason 3 O O
on Reason 3 O O
three Reason 3 O O
major Reason 3 O O
databases Reason 3 O O
of Reason 3 O O
CNKI, Reason 3 O O
WangFang, Reason 3 O O
and Reason 3 O O
VIP Reason 3 O O
in Reason 3 O O
Chinese. Reason 3 O O
Selection Reason 3 O O
of Reason 3 O O
publications Reason 3 O O
and Reason 3 O O
data Reason 3 O O
extraction Reason 3 O O
were Reason 3 O O
performed Reason 3 O O
by Reason 3 O O
two Reason 3 O O
investigators Reason 3 O O
independently, Reason 3 O O
according Reason 3 O O
to Reason 3 O O
the Reason 3 O O
predefined Reason 3 O O
criteria Reason 3 O O
of Reason 3 O O
inclusion Reason 3 O O
and Reason 3 O O
exclusion. Reason 3 O O
A Reason 3 O O
meta-analysis Reason 3 O O
was Reason 3 O O
carried Reason 3 O O
out Reason 3 O O
to Reason 3 O O
obtain Reason 3 O O
the Reason 3 O O
estimates Reason 3 O O
of Reason 3 O O
pooled Reason 3 O O
prevalence Reason 3 O O
of Reason 3 O O
cancer Reason 3 O O
in Reason 3 O O
patients Reason 3 O O
with Reason 3 O O
COVID-19 Reason 3 O O
and Reason 3 O O
estimate Reason 3 O O
the Reason 3 O O
odds Reason 3 O O
ratio Reason 3 O O
for Reason 3 O O
the Reason 3 O O
association Reason 3 O O
of Reason 3 O O
cancer Reason 3 O O
with Reason 3 O O
severe Reason 3 O O
events, Reason 3 O O
using Reason 3 O O
fixedeffect Reason 3 O O
or Reason 3 O O
random-effect Reason 3 O O
model Reason 3 O O
when Reason 3 O O
there Reason 3 O O
was Reason 3 O O
significant Reason 3 O O
heterogeneity Reason 3 O O
between Reason 3 O O
studies; Reason 3 O O
subgroup Reason 3 O O
analysis Reason 3 O O
was Reason 3 O O
also Reason 3 O O
conducted Reason 3 O O
by Reason 3 O O
some Reason 3 O O
characteristics Reason 3 O O
of Reason 3 O O
the Reason 3 O O
samples. Reason 3 O O
Potential Reason 3 O O
publication Reason 3 O O
bias Reason 3 O O
was Reason 3 O O
assessed Reason 3 O O
using Reason 3 O O
Begg's Reason 3 O O
and Reason 3 O O
Egger's Reason 3 O O
test Reason 3 O O
and Reason 3 O O
corrected Reason 3 O O
using Reason 3 O O
the Reason 3 O O
"trim Reason 3 O O
and Reason 3 O O
fill" Reason 3 O O
method Reason 3 O O
when Reason 3 O O
necessary. Reason 3 O O
Findings: Reason 3 O O
A Reason 3 O O
total Reason 3 O O
of Reason 3 O O
38 Reason 3 O O
studies Reason 3 O O
met Reason 3 O O
the Reason 3 O O
criteria Reason 3 O O
for Reason 3 O O
meta-analysis, Reason 3 O O
comprising Reason 3 O O
7,094 Reason 3 O O
patients Reason 3 O O
with Reason 3 O O
COVID-9. Reason 3 O O
The Reason 3 O O
pooled Reason 3 O O
prevalence Reason 3 O O
of Reason 3 O O
cancer Reason 3 O O
in Reason 3 O O
patients Reason 3 O O
with Reason 3 O O
COVID-19 Reason 3 O O
was Reason 3 O O
estimated Reason 3 O O
with Reason 3 O O
random-effect Reason 3 O O
model Reason 3 O O
at Reason 3 O O
2.3% Reason 3 O O
province, Reason 3 O O
and Reason 3 O O
the Reason 3 O O
corresponding Reason 3 O O
estimates Reason 3 O O
were Reason 3 O O
1.4% Reason 3 O O
and Reason 3 O O
1.9% Reason 3 O O
after Reason 3 O O
corrections Reason 3 O O
for Reason 3 O O
publication Reason 3 O O
bias, Reason 3 O O
respectively. Reason 3 O O
Cancer O O O O
was O O O O
significantly O O O O
associated O O O O
with O O O O
severe O O O O
cases O O O O
(Odd O O O O
ratio[OR]=2.20, O O O O
patients O O O O
with O O O O
COVID-19, O O O O
no O O O O
significant O O O O
heterogeneity O O O O
between O O O O
studies O O O O
and O O O O
a O O O O
minimal O O O O
publication O O O O
bias O O O O
according O O O O
to O O O O
the O O O O
Begg's O O O O
and O O O O
Egger's O O O O
test. O O O O
Interpretation: Reason 5 O O
We Reason 5 O O
conclude Reason 5 O O
that Reason 5 O O
cancer Reason 5 O O
is Reason 5 O O
associated Reason 5 O O
with Reason 5 O O
the Reason 5 O O
risk Reason 5 O O
and Reason 5 O O
severe Reason 5 O O
events Reason 5 O O
of Reason 5 O O
COVID-19. Reason 5 O O
Special Reason 5 O O
measures Reason 5 O O
should Reason 5 O O
be Reason 5 O O
taken Reason 5 O O
to Reason 5 O O
preventing Reason 5 O O
individuals Reason 5 O O
with Reason 5 O O
cancer Reason 5 O O
from Reason 5 O O
infection Reason 5 O O
and Reason 5 O O
managing Reason 5 O O
the Reason 5 O O
patients Reason 5 O O
of Reason 5 O O
cancer Reason 5 O O
with Reason 5 O O
COVID-19. Reason 5 O O
Funding Reason 5 O O
Statement: Reason 5 O O
The Reason 5 O O
study Reason 5 O O
supported Reason 5 O O
by Reason 5 O O
the Reason 5 O O
Key Reason 5 O O
Research Reason 5 O O
Project Reason 5 O O
of Reason 5 O O
Beijing Reason 5 O O
University Reason 5 O O
of Reason 5 O O
Chinese Reason 5 O O
Medicine Reason 5 O O
(2020-JYB-ZDGG-143-1), Reason 5 O O
National Reason 5 O O
Natural Reason 5 O O
Science Reason 5 O O
Foundation Reason 5 O O
of Reason 5 O O
China Reason 5 O O
(81573736) Reason 5 O O
and Reason 5 O O
Beijing Reason 5 O O
Haiju Reason 5 O O
Scholarship Reason 5 O O
(BHTO201511097). Reason 5 O O
Declaration Reason 5 O O
of Reason 5 O O
Interests: Reason 5 O O
All Reason 5 O O
authors Reason 5 O O
declare Reason 5 O O
no Reason 5 O O
conflicts Reason 5 O O
of Reason 5 O O
interest. Reason 5 O O
Keywords: Reason 5 O O
